Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
This advanced combination helps reduce melanin production, lighten hyperpigmentation, and improve overall skin tone
Vlasia Kastrinou-Lampou discusses her work published with Novartis on the role of bile acids in drug-induced liver injury (DILI) and how transporter and enzyme interaction testing can inform DILI prediction and de-risking
Confirm the update with your software vendor using the CMS CY 2026 MPFS Final Rule as the reference document, and verify the transmittal implementation date of April 6, 2026, against your system's last fee schedule refresh per CMS Transmittal 13673
The pilot program will offer coverage for the following GLP-1 medications approved for weight loss: the pill and injectable formulations of Wegovy, the KwikPen formulation of Zepbound, and the Foundayo pill
Lactobacillus fermentum ME-3 an antimicrobial and antioxidative probiotic
